CB2 Receptor Involvement in the Treatment of Substance Use Disorders
The pharmacological modulation of the cannabinoid receptor 2 (CB2r) has emerged as a promising potential therapeutic option in addiction. The purpose of this review was to determine the functional involvement of CB2r in the effects produced by drugs of abuse at the central nervous system (CNS) level...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-10-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/11/11/1556 |
| _version_ | 1797511087784984576 |
|---|---|
| author | Francisco Navarrete María S. García-Gutiérrez Ani Gasparyan Daniela Navarro Jorge Manzanares |
| author_facet | Francisco Navarrete María S. García-Gutiérrez Ani Gasparyan Daniela Navarro Jorge Manzanares |
| author_sort | Francisco Navarrete |
| collection | DOAJ |
| description | The pharmacological modulation of the cannabinoid receptor 2 (CB2r) has emerged as a promising potential therapeutic option in addiction. The purpose of this review was to determine the functional involvement of CB2r in the effects produced by drugs of abuse at the central nervous system (CNS) level by assessing evidence from preclinical and clinical studies. In rodents, several reports suggest the functional involvement of CB2r in the effects produced by drugs of abuse such as alcohol, cocaine, or nicotine. In addition, the discovery of CB2r in brain areas that are part of the reward system supports the relevance of CB2r in the field of addiction. Interestingly, animal studies support that the CB2r regulates anxiety and depression behavioral traits. Due to its frequent comorbidity with neuropsychiatric disorders, these pharmacological actions may be of great interest in managing SUD. Preliminary clinical trials are focused on exploring the therapeutic potential of modulating CB2r in treating addictive disorders. These promising results support the development of new pharmacological tools regulating the CB2r that may help to increase the therapeutic success in the management of SUD. |
| first_indexed | 2024-03-10T05:41:27Z |
| format | Article |
| id | doaj.art-9a2301fb7cdd4bb6b91e343bb7702204 |
| institution | Directory Open Access Journal |
| issn | 2218-273X |
| language | English |
| last_indexed | 2024-03-10T05:41:27Z |
| publishDate | 2021-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomolecules |
| spelling | doaj.art-9a2301fb7cdd4bb6b91e343bb77022042023-11-22T22:32:54ZengMDPI AGBiomolecules2218-273X2021-10-011111155610.3390/biom11111556CB2 Receptor Involvement in the Treatment of Substance Use DisordersFrancisco Navarrete0María S. García-Gutiérrez1Ani Gasparyan2Daniela Navarro3Jorge Manzanares4Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda. de Ramón y Cajal s/n, San Juan de Alicante, 03550 Alicante, SpainInstituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda. de Ramón y Cajal s/n, San Juan de Alicante, 03550 Alicante, SpainInstituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda. de Ramón y Cajal s/n, San Juan de Alicante, 03550 Alicante, SpainInstituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda. de Ramón y Cajal s/n, San Juan de Alicante, 03550 Alicante, SpainInstituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda. de Ramón y Cajal s/n, San Juan de Alicante, 03550 Alicante, SpainThe pharmacological modulation of the cannabinoid receptor 2 (CB2r) has emerged as a promising potential therapeutic option in addiction. The purpose of this review was to determine the functional involvement of CB2r in the effects produced by drugs of abuse at the central nervous system (CNS) level by assessing evidence from preclinical and clinical studies. In rodents, several reports suggest the functional involvement of CB2r in the effects produced by drugs of abuse such as alcohol, cocaine, or nicotine. In addition, the discovery of CB2r in brain areas that are part of the reward system supports the relevance of CB2r in the field of addiction. Interestingly, animal studies support that the CB2r regulates anxiety and depression behavioral traits. Due to its frequent comorbidity with neuropsychiatric disorders, these pharmacological actions may be of great interest in managing SUD. Preliminary clinical trials are focused on exploring the therapeutic potential of modulating CB2r in treating addictive disorders. These promising results support the development of new pharmacological tools regulating the CB2r that may help to increase the therapeutic success in the management of SUD.https://www.mdpi.com/2218-273X/11/11/1556cannabinoid 2 receptorsubstance use disorderreward systemalcoholcocainenicotine |
| spellingShingle | Francisco Navarrete María S. García-Gutiérrez Ani Gasparyan Daniela Navarro Jorge Manzanares CB2 Receptor Involvement in the Treatment of Substance Use Disorders Biomolecules cannabinoid 2 receptor substance use disorder reward system alcohol cocaine nicotine |
| title | CB2 Receptor Involvement in the Treatment of Substance Use Disorders |
| title_full | CB2 Receptor Involvement in the Treatment of Substance Use Disorders |
| title_fullStr | CB2 Receptor Involvement in the Treatment of Substance Use Disorders |
| title_full_unstemmed | CB2 Receptor Involvement in the Treatment of Substance Use Disorders |
| title_short | CB2 Receptor Involvement in the Treatment of Substance Use Disorders |
| title_sort | cb2 receptor involvement in the treatment of substance use disorders |
| topic | cannabinoid 2 receptor substance use disorder reward system alcohol cocaine nicotine |
| url | https://www.mdpi.com/2218-273X/11/11/1556 |
| work_keys_str_mv | AT francisconavarrete cb2receptorinvolvementinthetreatmentofsubstanceusedisorders AT mariasgarciagutierrez cb2receptorinvolvementinthetreatmentofsubstanceusedisorders AT anigasparyan cb2receptorinvolvementinthetreatmentofsubstanceusedisorders AT danielanavarro cb2receptorinvolvementinthetreatmentofsubstanceusedisorders AT jorgemanzanares cb2receptorinvolvementinthetreatmentofsubstanceusedisorders |